Table 2. Study design, sample size, interventional group, control, and age group.

TPTD: teriparatide; ALN: alendronate; BMD: bone mineral density; vBMD: volumetric bone mineral density; QoL: quality of life

Author, year	Study design	Sample size	Interventional group	Control	Patient age
Hagino et al.,  2024 [12]	RCT	559	202	357	Women aged 75 years or older; mean age = 81 years
Ganapathy et al., 2023 [13]	RCT	86	28	58	Women aged 54-70 years
Mori et al.,  2023 [14]	RCT	1011	505	506	Women aged at least 75 years
Ikeda et al., 2019 [15]	RCT	96	48	48	Women aged at least 65 years
Hagino et al., 2021 [16]	RCT	1011	505	506	Women aged at least 75 years